Morepen Laboratories' Stock Surges to New High, Garnering Attention from MarketsMOJO
Morepen Laboratories, a midcap pharmaceutical company, has gained attention in the stock market with a 5.08% increase in stock price on September 10th, reaching a new 52-week high of Rs.99.2. MarketsMojo has given a 'Buy' call for the stock, which has outperformed the sector by 4.21% and is trading above its moving averages.
Morepen Laboratories, a midcap pharmaceutical company, has been making headlines in the stock market with its recent surge in stock price. On September 10th, the company's stock gained 5.08%, closing at a new 52-week high of Rs.99.2. This positive performance has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock.
The stock has been on a winning streak for the past two days, with a consecutive gain of 10.87%. This has also outperformed the sector by 4.21%, showcasing the company's strong performance in the pharmaceutical industry.
Intraday trading saw the stock reach a high of Rs.99.2, a 5.45% increase from the previous day. Morepen Laboratories is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance.
In comparison to the Sensex, Morepen Laboratories has outperformed with a 1-day performance of 6.73% versus the Sensex's 0.05%. Over the past month, the stock has shown a remarkable 72.72% increase, while the Sensex has only seen a 2.38% increase.
With such impressive numbers, it's no surprise that MarketsMOJO has given a 'Buy' call for Morepen Laboratories. As a midcap company in the pharmaceutical industry, Morepen Laboratories is definitely one to watch in the stock market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
